top of page
Title_v5.png

APPs play a vital role in the care and management of patients with lupus, which is often underdiagnosed. Since SLE is under diagnosed, it is therefore undertreated, and care is often suboptimal especially in high-risk communities. RhAPP is committed to providing education and opportunities that improve access to care for patients in high-risk communities, especially in areas with vulnerable populations. To address this need, RhAPP will host a series of patient education seminars being held in cities across the country. Additional details on locations and dates will be available in the coming weeks!

 

RhAPP is also pleased to provide education specifically designed for APPs on the diagnosis and management of lupus. By advancing education for APPs in lupus, we aim to close gaps in patient care which will lead to improved patient outcomes. RhAPP has launched a publication that will provide in-depth education addressing the diagnosis and care of specific patient populations who are at the most risk for underdiagnosis. To read and download the publication, please click the button below.

Nationwide Regional Meetings

Houston Meeting

New York Meeting

Content and materials were developed by RhAPP in consultation with Lupus Research Alliance/Lupus Therapeutics.

Comments by presenters may not reflect the views of either organization. Both organizations uphold the highest ethical standards and maintain editorial control of all educational materials published.

GSK_Signal_Full_Colour_RGB[1]_GSK_Signal_Full_Colour_RGB.png

This initiative is supported by a sponsorship from GlaxoSmithKline, LLC.

LRA_Lupus_Therapeutics_logo.png
RhAPP Logo.png
NY registration

Become a RhAPP Member

bottom of page